Compugen (CGEN) Gross Margin (2009 - 2026)
Compugen recorded quarterly Gross Margin of 16.18% in Q1 2026, up 418.51% quarter-over-quarter from 5.08% in Q1 2025, and up 2126.0% year-over-year from 0.73% in Q1 2025.
Compugen's Gross Margin history runs 2 years deep, the most recent figure standing at 16.18% for Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 82.22% |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 16.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.18% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 12.74% |
| Jun 30, 2025 | -32.46% |
| Mar 31, 2025 | -5.08% |
| Dec 31, 2024 | 54.11% |
| Sep 30, 2024 | 78.98% |
| Jun 30, 2024 | 76.84% |
| Mar 31, 2024 | 17.86% |
| Dec 31, 2023 | 94.01% |
| Dec 31, 2022 | 87.00% |
| Dec 31, 2020 | 97.00% |
| Sep 30, 2018 | 91.23% |
| Dec 31, 2016 | 33.96% |
| Sep 30, 2016 | 70.00% |
| Jun 30, 2016 | 82.66% |
| Mar 31, 2016 | 12.90% |
| Dec 31, 2015 | 87.54% |
| Sep 30, 2015 | 12.23% |
| Jun 30, 2015 | 33.63% |
| Mar 31, 2015 | 25.54% |
| Dec 31, 2014 | 84.94% |
| Sep 30, 2014 | 56.87% |
| Jun 30, 2014 | 56.26% |
| Mar 31, 2014 | 64.51% |
| Dec 31, 2013 | 54.37% |
| Sep 30, 2013 | 7.86% |
| Jun 30, 2013 | -281.82% |
| Mar 31, 2013 | 7.41% |
| Dec 31, 2012 | -25.37% |
| Sep 30, 2012 | 69.44% |
| Dec 31, 2010 | 86.32% |
| Jun 30, 2010 | 75.25% |
| Mar 31, 2010 | -50.40% |
| Dec 31, 2009 | 100.00% |
| Sep 30, 2009 | 282.29% |